Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China · Delayed Price · Currency is CNY 7.87
-0.14 (-1.75%)
Jun 2, 2026, 3:00 PM CST
SHA:688098 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.68 | -24.97 | -44.74 | 31.52 | 61.1 | 110.2 |
Depreciation & Amortization | 75.43 | 75.43 | 68.36 | 63.45 | 57.07 | 43.74 |
Other Amortization | - | - | 0.28 | - | - | - |
Loss (Gain) From Sale of Assets | -0.26 | -0.26 | -0.04 | -0 | -0.14 | 0.6 |
Asset Writedown & Restructuring Costs | -2.37 | -2.37 | 28.46 | 0.4 | 0.24 | - |
Loss (Gain) From Sale of Investments | 3 | 3 | -2.67 | -5.79 | -3.31 | -12.08 |
Provision & Write-off of Bad Debts | - | - | 8.45 | 3.12 | 8.5 | 1.65 |
Other Operating Activities | 1.1 | 13.9 | -3.93 | -1.68 | -0.11 | -5.82 |
Change in Accounts Receivable | -34.22 | -34.22 | 5.03 | -52.18 | -78.96 | -27.68 |
Change in Inventory | 0.64 | 0.64 | 16.68 | 3.58 | -11.9 | -32.27 |
Change in Accounts Payable | 3.29 | 3.29 | 21.42 | -33.15 | -17.88 | 5.25 |
Change in Other Net Operating Assets | - | - | - | -6.81 | -6.14 | 5.07 |
Operating Cash Flow | 21.56 | 33.08 | 89.36 | 3.53 | 9.09 | 90.12 |
Operating Cash Flow Growth | -74.69% | -62.99% | 2434.71% | -61.21% | -89.92% | -19.34% |
Capital Expenditures | -41.96 | -45.23 | -84.91 | -129.63 | -93.12 | -188.16 |
Sale of Property, Plant & Equipment | 0.52 | 0.52 | - | - | 0.86 | 0.5 |
Investment in Securities | -26.46 | -8 | 78.94 | 141.45 | 119.3 | 49.4 |
Other Investing Activities | 3.41 | 3.55 | 2.29 | 10.05 | 8.98 | 11.06 |
Investing Cash Flow | -64.5 | -49.16 | -3.68 | 21.86 | 36.01 | -127.21 |
Long-Term Debt Issued | - | - | 14 | - | - | - |
Total Debt Issued | - | - | 14 | - | - | - |
Long-Term Debt Repaid | - | -1.12 | -0.78 | -0.37 | -0.12 | -0.14 |
Net Debt Issued (Repaid) | -1.12 | -1.12 | 13.22 | -0.37 | -0.12 | -0.14 |
Issuance of Common Stock | - | - | - | - | - | 8.14 |
Common Dividends Paid | -0.26 | -0.27 | -14.35 | -32.77 | -36.81 | -40.81 |
Other Financing Activities | -0.37 | -2.12 | -18.23 | 0.05 | 0.24 | 0.51 |
Financing Cash Flow | -1.75 | -3.51 | -19.36 | -33.09 | -36.7 | -32.3 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | 0 | -0 |
Net Cash Flow | -44.69 | -19.59 | 66.33 | -7.71 | 8.4 | -69.39 |
Free Cash Flow | -20.4 | -12.16 | 4.45 | -126.11 | -84.04 | -98.04 |
Free Cash Flow Margin | -7.50% | -4.22% | 1.47% | -41.83% | -25.57% | -27.35% |
Free Cash Flow Per Share | - | -0.03 | 0.01 | -0.32 | -0.21 | -0.24 |
Cash Income Tax Paid | 13.4 | 12.23 | 15.06 | 30.93 | 24.25 | 28.43 |
Levered Free Cash Flow | 12.76 | 19.38 | 18.35 | -113.08 | -92.62 | -126.34 |
Unlevered Free Cash Flow | 13 | 19.38 | 18.36 | -113.08 | -92.62 | -126.34 |
Change in Working Capital | -31.66 | -31.66 | 35.19 | -87.5 | -114.26 | -48.17 |